Novo Nordisk Malaysia

Last updated: 15.09.2014

novo nordiskNovo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

Headquartered in Denmark, Novo Nordisk employs approximately 40,700 employees in 75 countries, and markets its products in more than 180 countries.

Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO).

Novo Nordisk Pharma (Malaysia) Sdn. Bhd.
A-9-2 Level 9, Tower A, Menara UOA Bangsar,
No.5 Jalan Bangsar Utama 1 59000 Kuala Lumpur



We use cookies to ensure that we give you the best experience on our site. For more info click here